If you want to protect your right to access legal cannabis without threat of DEA or FDA interference, tell your Congressional reps to pass the States Act.
The AZ Supreme Court rules in favor of AMMA patient Rodney Jones, convicted and incarcerated for cannabis possession after his 2013 arrest in Yavapai County
Read The Cannabis Reporter Pro Series Interview with Dustin Byars, Head of Operations at Sunstate Technology Group Hosted by Snowden Bishop
Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to advance regulatory pathways for cannabis-containing and cannabis-derived products
FDA rules could have grave consequences for the CBD industry unless stakeholders are informed, compliant and engaged in policy. Here’s a call to action.
Technology solutions are a great way for dispensary owners to manage customer queries. Interactive kiosks, can be a deep source of information for consumers
NewsBank licenses The Cannabis Reporter’s original content for distribution to libraries and academic, government, military and research institutions
Mexico’s President Elect Andrés Manuel López Obrador declared an official end to the drug war that has ravaged his country in a move toward peace.
Canadian cannabis companies, Aurora Cannabis and MedReleaf, join forces to create one of the largest vertically-integrated cannabis operations in Ontario
Cannabis industry was blindsided when news broke about the California Department of Public Health (CDPH) decision to ban the sale any food or dietary supplement containing CBD.
AZ Patients Beware: “Cannabis Is Not Marijuana” and Thus Illegal According to State’s Appellate Court Ruling
Arizona Appellate Court ruling earlier this week essentially gutted the Arizona Medical Marijuana Act (AMMA) by re-defining “marijuana” as justification to deny the appeal to overturn the felony conviction handed to Rodney Christopher Jones, a card-carrying medical marijuana patient from Yavapai County. Initially arrested and charged with felony possession of cannabis and paraphernalia in 2013 — three…
it became apparent that legislation calling for the removal hemp from Schedule One Controlled Substances may finally have a chance of becoming law, sort of.
Former pharmaceutical executives explain how solving the cannabis industry’s fragmented infrastructure could be as simple as taking a page from the pharmaceutical play book.